Insider Trading activities of Ocular Therapeutix, Inc (OCUL)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ocular Therapeutix, Inc (OCUL) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ocular Therapeutix, Inc since year 2005. Table 2 shows the detailed insider transactions of Ocular Therapeutix, Inc since 2005. The reporting company's ticker symbol is OCUL. The reporting company's CIK number is 1393434.
The total value of stock buying since 2005 is $14,272,035.
The total value of stock sales since 2005 is $72,398,505.
The total value of stock option exercises since 2005 is $656,149.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Ocular Therapeutix, Inc (OCUL).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-03 90,441 $385,489 0 $0 0 $0
2018-12 37,400 $211,224 0 $0 0 $0
2018-08 49,400 $302,912 0 $0 0 $0
2017-12 50,500 $206,361 0 $0 189,393 $494,315
2017-11 19,000 $98,420 0 $0 0 $0
2016-12 45,300 $355,605 0 $0 0 $0
2016-08 0 $0 0 $0 58,357 $78,781
2016-06 10,000 $67,000 0 $0 0 $0
2015-11 10,000 $82,500 0 $0 0 $0
2015-09 15,000 $249,600 9,470 $162,505 0 $0
2015-06 0 $0 2,613,000 $57,486,000 0 $0
2015-05 0 $0 0 $0 51,491 $69,512
2015-02 0 $0 500,000 $14,750,000 24,620 $13,541
2014-07 947,148 $12,312,924 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Ocular Therapeutix, Inc insiders (OCUL)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-03-15 Goldstein Michael H. (Chief Medical Officer) Buy 10,000 4.15 41,500
2019-03-15 Heier Jeffrey S. (Director) Buy 24,000 4.15 99,600
2019-03-13 Lindstrom Richard L Md (Director) Buy 56,441 4.33 244,389
2018-12-14 Hanley Kevin F. (See Remarks) Buy 10,000 5.50 55,000
2018-12-10 Hanley Kevin F. (SEE REMARKS) Buy 10,000 5.60 56,000
2018-12-06 Bollag Daniel M (See Remarks) Buy 17,400 5.76 100,224
2018-08-20 Mattessich Antony C. (President & CEO) Buy 20,000 5.95 119,000
2018-08-14 Notman Donald (Chief Financial Officer) Buy 12,500 6.29 78,625
2018-08-10 Mattessich Antony C. (President and CEO) Buy 16,900 6.23 105,287
2017-12-21 Sawhney Amarpreet (Exec Chairman of the Board) Option Ex 189,393 2.61 494,315
2017-12-12 Mattessich Antony C. (President and C.E.O.) Buy 21,000 4.29 90,090
2017-12-07 Notman Donald (Chief Financial Officer) Buy 4,800 4.00 19,200
2017-12-06 Bollag Daniel M (See Remarks) Buy 24,700 3.93 97,071
2017-11-16 Sawhney Amarpreet (Exec. Chairman of the Board) Buy 19,000 5.18 98,420
2016-12-15 Sawhney Amarpreet (President and CEO) Buy 45,300 7.85 355,605
2016-08-05 Sawhney Amarpreet (President and CEO) Option Ex 58,357 1.35 78,781
2016-06-09 Sawhney Amarpreet (President and CEO) Buy 10,000 6.70 67,000
2015-11-17 Sawhney Amarpreet (President and CEO) Buy 10,000 8.25 82,500
2015-09-15 Fortune James (Chief Operating Officer) Sale 9,470 17.16 162,505
2015-09-14 Sawhney Amarpreet (President and CEO) Buy 15,000 16.64 249,600
2015-06-15 Versant Side Fund Iii, L.p. (10% Owner) Sale 320,000 22.00 7,040,000
2015-06-15 Warden Charles M (Director) Sale 320,000 22.00 7,040,000
2015-06-10 Versant Side Fund Iii, L.p. (10% Owner) Sale 427,000 22.00 9,394,000
2015-06-10 Sv Life Sciences Fund Iv Strategic Partners, L. P. (10% Owner) Sale 1,119,000 22.00 24,618,000
2015-06-10 Warden Charles M (Director) Sale 427,000 22.00 9,394,000
2015-05-13 Sawhney Amarpreet (President and CEO) Option Ex 51,491 1.35 69,512
2015-02-27 Lindstrom Richard L Md (Director) Option Ex 24,620 .55 13,541
2015-02-02 Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) Sale 500,000 29.50 14,750,000
2014-07-30 Ascension Health Ventures Ii, Llc (10% Owner) Buy 153,846 13.00 1,999,998
2014-07-30 Ankerud Eric (See Remarks) Buy 1,000 13.00 13,000
2014-07-30 Sawhney Amarpreet (President and CEO) Buy 76,922 13.00 999,986
2014-07-30 Sv Life Sciences Fund Iv (gp), L.p. (10% Owner) Buy 715,380 13.00 9,299,940

Insider trading activities including stock purchases, stock sales, and option exercises of OCUL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ocular Therapeutix, Inc (symbol OCUL, CIK number 1393434) see the Securities and Exchange Commission (SEC) website.